Under construction – not a live service
Sign in

2023-507348-35-00RecruitingPhase 4

Anti-viral action against Type 1 diabetes autoimmunity GPPAD-05-AVAnT1A

Source: EU CTIS (euclinicaltrials.eu) · Last updated 22 Oct 2026

Next steps

Brief summary (registry, in English)

To determine whether vaccination of children with elevated genetic risk for type 1 diabetes against COVID-19 from 6 months of age reduces the cumulative incidence of islet autoantibodies or type 1 diabetes in child-hood.

Status (registry)
Recruiting
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
2365 (estimated)
First submitted
8 Dec 2023
Start date
30 May 2024
Lead sponsor
Klinikum rechts der Isar der TU Muenchen AöR
EU CT number
2023-507348-35-00

What you commit to

  • Study type: Interventional · Phase 4
  • Planned participants: 2365
  • 9 sites in 6 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Any medical condition, concomitant disease or treatment that may interfere with the assessments or may jeopardize the participant’s safe participation in the study. These include immune deficiencies, and conditions or treatments that lead to immune suppression.
  • Diagnosis of diabetes prior to recruitment or randomisation
  • Current use of any other investigational drug
  • Previous hypersensitivity to the excipients of the vaccine

Other

  • Likely poor compliance due to expected change in residency.

Who the study is looking for

  • Ages between 3.00 and 4.00 months at the time of enrollment
  • A high genetic risk (>10%) to develop islet autoantibodies by age 6 years as determined by a HLA DR/DQ genotype, polygenic risk score and first-degree family history of type 1 diabetes status
  • Written informed consent signed by the custodial parent(s)

Age in the registry: - to 17 years · Sex: All · Accepts healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (9)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Medical University of ViennaViennaAustriaRecruiting
UZ LeuvenLeuvenBelgiumRecruiting
Technische Universität DresdenDresdenGermanyRecruiting
Hannoversche KinderheilanstaltHanoverGermanyRecruiting
Klinikum rechts der Isar der TU Muenchen AöRMunichGermanyRecruiting
Istituto San RaffaeleMilanItalyNot yet recruiting
Clinical Trials Umed Sp. z o.o.LodzPolandWithdrawn
Warszawski Uniwersytet MedycznyWarsawPolandWithdrawn
Region Skane Skanes UniversitetssjukhusMalmoSwedenRecruiting

Are you the coordinator? Confirm the details

This page is information, not medical advice. Discuss any trial with your doctor.